Unknown

Dataset Information

0

CAR T-cell immunotherapy of B-cell malignancy: the story so far.


ABSTRACT: Chimeric antigen receptor (CAR) T-cell immunotherapy has achieved unprecedented efficacy in the treatment of chemotherapy-resistant or refractory B-cell malignancies. Promising results from pivotal anti-CD19 CAR T-cell phase II trials have led to landmark approvals of two CD19-specific CAR T-cell products by the United States Food and Drug Administration and European Medicines Agency. However, several issues associated with CAR T-cell treatment remain unresolved, such as the management of severe toxicities and the frequent occurrence of both antigen-positive and antigen-negative relapse. Nonetheless, pre-clinical research is advancing at an unprecedented pace to develop innovative solutions to address these issues. Herein, we summarise recent clinical developments and outcomes of CD19-targeted CAR T-cell immunotherapy and discuss emerging strategies that may further improve the success, safety and broadened applicability of this approach.

SUBMITTER: Halim L 

PROVIDER: S-EPMC7257863 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

CAR T-cell immunotherapy of B-cell malignancy: the story so far.

Halim Leena L   Maher John J  

Therapeutic advances in vaccines and immunotherapy 20200527


Chimeric antigen receptor (CAR) T-cell immunotherapy has achieved unprecedented efficacy in the treatment of chemotherapy-resistant or refractory B-cell malignancies. Promising results from pivotal anti-CD19 CAR T-cell phase II trials have led to landmark approvals of two CD19-specific CAR T-cell products by the United States Food and Drug Administration and European Medicines Agency. However, several issues associated with CAR T-cell treatment remain unresolved, such as the management of severe  ...[more]

Similar Datasets

| S-EPMC7339067 | biostudies-literature
| S-EPMC10163725 | biostudies-literature
| S-EPMC4817890 | biostudies-other
| S-EPMC5706532 | biostudies-literature
| S-EPMC8223062 | biostudies-literature
| S-EPMC8409419 | biostudies-literature
| S-EPMC8185049 | biostudies-literature
| S-EPMC7012264 | biostudies-literature
| S-EPMC9727400 | biostudies-literature
| S-EPMC8969382 | biostudies-literature